Mercer Capital Advisers’s Allergan plc AGN Stock Holding History

Mercer Capital Advisers’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-195	Closed	-$52K	–	284
2016 Q1	$52K	Hold	195	–	–	0.04%	155
2015 Q4	$61K	Hold	195	–	–	0.05%	145
2015 Q3	$53K	Hold	195	–	–	0.05%	155
2015 Q2	$59K	Hold	195	–	–	0.05%	156
2015 Q1	$58K	Hold	195	–	–	0.05%	158
2014 Q4	$50K	Buy	+195	New	+$48.7K	0.04%	170

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Mercer Capital Advisers's AGN Position: Q2 2016 in Review

Mercer Capital Advisers sold out of Allergan plc (AGN) in Q2 2016, closing a stake of 195 shares — an estimated $52K sold.

Mercer Capital Advisers first reported a position in AGN in Q4 2014 and held it in 6 quarters. The position peaked at $61K in Q4 2015. 1,107 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

Mercer Capital Advisers reported no remaining Allergan plc position as of Q2 2016 after selling out during the quarter.
Mercer Capital Advisers sold 195 Allergan plc shares in Q2 2016, an estimated $52K.
Mercer Capital Advisers first reported a position in Allergan plc in Q4 2014 and held it in 6 quarters.
Mercer Capital Advisers's Allergan plc position peaked at $61K in Q4 2015.
1,107 funds tracked by Wall St. Rank held Allergan plc as of Q2 2016.

Based on Mercer Capital Advisers's 13F filing for Q2 2016, filed 22 Jul 2016.